A Randomized Study Comparing the Efficacy of Bevacizumab and Ranibizumab as Pre-treatment for Pars Plana Vitrectomy in Proliferative Diabetic Retinopathy
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,Surgery
Reference33 articles.
1. The 14-year incidence of visual loss in a diabetic population;Moss SE;Ophthalmology,1998
2. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24;Fong;Am J Ophthalmol,1999
3. [No authors listed]. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic retinopathy vitrectomy study report 5;Arch Ophthalmol,1990
4. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy;Chen E;Retina,2006
5. A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy;Zhao LQ;Br J Ophthalmol,2011
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy;Cochrane Database of Systematic Reviews;2023-05-31
2. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy;Frontiers in Endocrinology;2023-05-26
3. Appropriate timing schedule for intravitreal anti-VEGF injection as adjuvant therapy before pars-plana vitrectomy in proliferative diabetic retinopathy, a meta analysis;Expert Review of Ophthalmology;2023-05-04
4. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy;Frontiers in Endocrinology;2023-02-22
5. Study on the effects of ranibizumab as a pretreatment for vitrectomy in proliferative diabetic retinopathy: a retrospective cohort study;EUR REV MED PHARMACO;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3